These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33130461)

  • 1. Modelling multiple sclerosis using induced pluripotent stem cells.
    Martínez-Larrosa J; Matute-Blanch C; Montalban X; Comabella M
    J Neuroimmunol; 2020 Dec; 349():577425. PubMed ID: 33130461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
    Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
    Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Stem Cells as a Novel Multiple Sclerosis Therapy.
    Xie C; Liu YQ; Guan YT; Zhang GX
    Curr Stem Cell Res Ther; 2016; 11(4):313-20. PubMed ID: 25732737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases.
    De Filippis L; Zalfa C; Ferrari D
    CNS Neurol Disord Drug Targets; 2017; 16(8):915-926. PubMed ID: 28641519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of defined neural populations from pluripotent stem cells.
    McComish SF; Caldwell MA
    Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
    Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
    Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.
    Rahimi Darehbagh R; Seyedoshohadaei SA; Ramezani R; Rezaei N
    Eur J Med Res; 2024 Jul; 29(1):386. PubMed ID: 39054501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating induced pluripotent stem cells for multiple sclerosis therapy.
    Fossati V; Douvaras P
    Regen Med; 2014; 9(6):709-11. PubMed ID: 25431906
    [No Abstract]   [Full Text] [Related]  

  • 11. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.
    Jung JH; Fu X; Yang PC
    Circ Res; 2017 Jan; 120(2):407-417. PubMed ID: 28104773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Induced Pluripotent Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow-Derived Schwann Cells: Implications for Remyelination Therapy.
    Cai S; Han L; Ao Q; Chan YS; Shum DK
    Stem Cells Transl Med; 2017 Feb; 6(2):369-381. PubMed ID: 28191772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini-Review: Induced pluripotent stem cells and the search for new cell-specific ALS therapeutic targets.
    Ferraiuolo L; Maragakis NJ
    Neurosci Lett; 2021 Jun; 755():135911. PubMed ID: 33892003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors:
    Kobayashi Y; Shigyo M; Platoshyn O; Marsala S; Kato T; Takamura N; Yoshida K; Kishino A; Bravo-Hernandez M; Juhas S; Juhasova J; Studenovska H; Proks V; Driscoll SP; Glenn TD; Pfaff SL; Ciacci JD; Marsala M
    Cell Transplant; 2023; 32():9636897221107009. PubMed ID: 37088987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine structure of neurally differentiated iPS cells generated from a multiple sclerosis (MS) patient: a case study.
    Herszfeld D; Payne NL; Sylvain A; Sun G; Bernard CC; Clark J; Sathananthan H
    Microsc Microanal; 2014 Dec; 20(6):1869-75. PubMed ID: 25335881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue.
    Chen SJ; Chang CM; Tsai SK; Chang YL; Chou SJ; Huang SS; Tai LK; Chen YC; Ku HH; Li HY; Chiou SH
    Stem Cells Dev; 2010 Nov; 19(11):1757-67. PubMed ID: 20192839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis.
    Clayton ZE; Sadeghipour S; Patel S
    Int J Cardiol; 2015 Oct; 197():116-22. PubMed ID: 26123569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.